Through an in vivo genetic screening in hematopoietic stem/progenitor cells, RING Finger Protein RNF144B was identified as a critical factor contributing to TRP53-mediated tumor suppression, in the context of blood cancers [23]. The gene discussed is TP53; the disease is hematopoietic and lymphoid system neoplasm.